It was, one could argue, yet another win for the Wolverine peptide. But Wolverine is a fictional superhero created by Marvel in the 1970s, with powers beyond the reach of real-life humans and peptide ...
Early-phase oncology trials carry substantial scientific and commercial risk in cancer drug development. Getting them right by optimizing strategy and design, and working with the right partners is ...
In large part wellness influencers have maintained the fad. One name that keeps coming up is an influencer named Gary Brecka, who is linked to Kennedy. It was on Brecka’s podcast that Kennedy ...
ImmunityBio, Inc. , a commercial stage immunotherapy company developing next generation therapies that drive immunological memory and restore immune competence, today announced that the Company held ...
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.
Upon ingestion, the new Enzian dosage form resides in the stomach for several hours and steadily delivers drug into the blood. This enables enhanced effectiveness of many life-saving drug therapies.
Solid Biosciences Inc. is a Strong Buy driven by positive FDA alignment on phase 3 IMPACT DUCHENNE trial for SGT-003. Read ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced full-year 2025 financial and operational highlights, including approximately $113 million in net product ...
Experts clear up 'concern' over side effects of drug used by millions Why Sydney's official Mardi Gras party was cancelled this year Richard Marles grilled on capital gains tax changes Prehistoric ...
Nio's position as the upside leader is driven by its depressed valuation. Trading near $4.60 per share, the stock is currently hovering just above the Street low of $4 set by Barclays in late 2025.
Apple in macOS Tahoe 26.2 introduced Edge Light, a clever new feature that turns your Mac's display into a virtual ring light during video calls. Instead of fumbling with external lighting equipment, ...